| Website | molecularimaging.com |
| Category | BioTech |
| Phone | 734-821-1063 |
| Employees |
| TOTAL | $9.9M |
| FUNDING TOTAL | $9.9M |
| Series A, 3/12 Baird Venture Partners Arcus Ventures Beringea Private Equity | $9.9M |
Molecular Imaging, Inc. is a specialty contract research organization (CRO) located in Ann Arbor, Michigan. Molecular Imaging employs a wide array of imaging technologies, including MRI, micro-CT, micro-PET and optical (two-dimensional and molecular fluorescence tomography) to quantitatively measure response to therapy at anatomical, functional and molecular levels. Molecular Imaging also conducts applications research to develop and optimize the use of imaging and actively seeks collaborations to further advance imaging in the field of drug discovery.